Resistell News:

Meet Resistell in Davos on 21.10.2021 at the 4th Swiss Symposium in Point-of-Care Diagnostics

Meet Resistell in Davos on 21.10.2021 at the 4th Swiss Symposium in Point-of-Care Diagnostics
Resistell News:

Meet Resistell in Davos on 21.10.2021 at the 4th Swiss Symposium in Point-of-Care Diagnostics

Meet Resistell's team at the Swiss Symposium in Point-of-Care Diagnostics and see live presentation of our technology.
Meet Resistell in Davos on 21.10.2021 at the 4th Swiss Symposium in Point-of-Care Diagnostics

Latest news

19th November 2020

Antimicrobials: handle with care by HEMEX

The World Antimicrobial Awareness Week (WAAW) starts today, and this year’s slogan highlights the importance of encouraging best practices when it comes to using antimicrobials. Our portfolio company Resistell is helping to reduce the spreading of antibiotic resistance with their rapid Antimicrobial Susceptibility Testing.
Resistell wins Special Life Science Award in Swiss Innovation Challenge 2020
16th November 2020

Resistell wins Special Life Science Award in Swiss Innovation Challenge 2020

Resistell, the start-up developing world’s fastest phenotypic antibiotic susceptibility test (rapid AST) won the Special Life Science Award in Swiss Innovation Challenge. The prestigious award is a great honour for Resistell and a huge confirmation for the whole team and the product itself.
Resistell among TOP 10 best start-ups in Switzerland
9th September 2020

Resistell among TOP 10 best start-ups in Switzerland

This year we’ve made a spectacular leap and **ranked 8th**, joining the league of TOP10 most promising start-ups in Switzerland in 2020.
Resistell technology in Frontiers in Mechanical Engineering
29th July 2020

Resistell technology in Frontiers in Mechanical Engineering

Nanomechanical Sensors as a Tool for Bacteria Detection and Antibiotic Susceptibility Testing
Resistell AG receives €2.5M EIC Accelerator grant and equity financing offer from EIC
3rd July 2020

Resistell AG receives €2.5M EIC Accelerator grant and equity financing offer from EIC

Resistell AG, the start-up developing world’s fastest phenotypic antibiotic susceptibility test was selected for funding under the European Innovation Council (EIC) programme in the latest funding round. Resistell’s project RAPID-SEP-AST will receive up to €2.5M grant and additional equity financing from EIC Fund.